Effect of carbamazepine, oxcarbazepine and lamotrigine on the increase in extracellular glutamate elicited by veratridine in rat cortex and striatum

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 354, Issue 2, 1996, Pages 164-172

  Waldmeier, P C ^a   Martin, P ^a   Stocklin K ^a   Portet, C ^a   Schmutz, M ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

carbamazepine; extracellular glutamate; lamotrigine; microdialysis; oxcarbazepine; veratridine

Indexed keywords

ASPARTIC ACID; CARBAMAZEPINE; GLUTAMIC ACID; LAMOTRIGINE; OXCARBAZEPINE; TETRODOTOXIN; VERATRIDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONVULSION; CORPUS STRIATUM; MALE; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT;

EID: 0030013035     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00178716     Document Type: Article

References (43)

1. +-evoked amino acid release in the ventral hippocampus of the rat in vivo. Br J Pharmacol 115, 116P
2. Andermann F (1994) Oxcarbazepine: experience and future role. Epilepsia 35 [Suppl 3]:S1-S31
3. Baltzer V, Schmutz M (1978) Experimental anticonvulsant properties of GP 47680 and of GP 47779, its main human metabolite; compounds related to carbamazepine. In: Meinardi H, Rowan AJ (eds) Advances in epileptology: 9th epilepsy int. symposium. Swets & Zeillinger B.V., Amsterdam, pp 295-299
4. Budavari S, O'Neill MJ, Smith A, Heckelman PE (1989) Merck Index, 11th edn. Merck & Co., Rahway
5. Butcher SP, Hamberger A (1987) In vivo studies on the extracellular, and veratrine-releasable, pools of endogenous amino acids in the rat striatum: effects of corticostriatal deafferentition and kainic acid lesion. J Neurochem 48:713-721
6. Cheung H, Kamp D, Harris E (1992) An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res 13:107-112
7. 2+ uptake and amino acid neurotransmitter release in vitro. Epilepsia 28:378-382
8. Dam M, Ekberg R, Loyning Y, Waltimo O, Jacobsen K (1989) A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. Epilepsy Res 3:70-76
9. Finney DJ (1971) Probit analysis, 3rd edn. Cambridge University Press, Cambridge
10. Goa KL, Ross SR, Chrisp P (1993) Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy. Drugs 46:152-176
11. Gram L, Philbert A (1986) Oxcarbazepine. In: Meldrum BS, Porter RJ (eds) New anticonvulsant drugs. John Libbey & Co., London, pp 229-235
12. Heron A, Lasbennes F, Seylaz J (1993) Adenosine modulation of amino acid release in rat hippocampus during ischemia and veratridine depolarization. Brain Res 608:27-32
13. Klosterskov-Jensen P, Gram L, Schmutz M (1991) Oxcarbazepine. In: Pisani F, Perucca E, Avanzini G, Richens A (eds) New antiepileptic drugs. Elsevier, Amsterdam, pp 135-140
14. Leach MJ, Marden CM, Miller AA (1986) Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia 27:490-497
15. Leach MJ, Baxter MG, Critchley MAE (1991) Neurochcmical and behavioral aspects of lamotrigine. Epilepsia 32 [Suppl 2]:S4-S8
16. Lees G, Leach MJ (1993) Studies on the mechanism of action of the novel anticonvulsant lamotrigine (lamictal) using primary neuroglial cultures from rat cortex. Brain Res 612:190-199
17. Löschmann P-A, Eblen F, Wüllner U, Wachtel H, Klockgether T (1995) Lamotrigine has no antiparkinsonian activity in rat models of Parkinson's disease. Eur J Pharmacol 284:129-134
18. 2+ influx in the hippocampus with in vivo intracerebral microdialysis. Br J Pharmacol 104:222-226
19. Macdonald RL (1988) Anticonvulsant drug actions on neurons in cell culture. J Neural Transm 72:173-183
20. Macdonald RL, Kelly KM (1994) Mechanisms of action of currently prescribed and newly developed antiepileptic drugs. Epilepsia 35 [Suppl 4]:S41-S50
21. Martin P, Bernasconi R, Schiesser A, Bechtold M, Bernasconi P (1989) A new automated on line precolumn derivatisation system based on the WISP autosampler for the separation of amino acids by high performance liquid chromatography (HPLC). 13th Symp Column Liquid Chrom (Stockholm June 25 30, 1989) W-P029- (p 43) (abstr)
22. Masuda Y, Utsui Y, Shiraishi Y, Karasawa T, Yoshida K, Shimizu M (1979) Relationships between plasma concentrations of diphenylhydantoin, phenobarbital, carbamazepine and 3-sulfamoyl-methyl-1,2-benzisoxazole (AD-810), a new anticonvulsant agent, and their anticonvulsant or neurotoxic effects in experimental animals. Epilepsia 20:623-633
23. Mattson RH, Cramer JA, Collins JF, Smith DB, Delgado-Escueta AV, Browne TR, Williamson PD, Treiman DM, McNamara JO, McCutchen CB, Homan RW, Crill WE, Lubozynski MF, Rosenthal NP, Mayersdorf A (1985) Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 313: 145-151
24. McLean MJ, Schmutz M, Wamil AW, Olpe HR, Portet C, Feldmann KF (1994) Oxcarbazepine: mechanism of action. Epilepsia 35 [Suppl 3]:S5-S9
25. McMahon HT, Nicholls DG (1991) The bioenergetics of neurotransmitter release. Biochim Biophys Acta 1059:243-264
26. Mendez-Alvarez E, Soto-Otero R, Galan-Valiente J, Sierra-Marcuño G (1990) Effect of phenobarbital on carbamazepine and its major metabolites in serum, different brain areas, and urine after acute and chronic administration to rats. Epilepsia 31:202-210
27. Miller AA, Wheatley P, Sawyer DA, Baxter MG, Roth B (1986) Pharmacological studies on lamotrigine, a novel potential antiepileptic drug. I. Anticonvulsant profile in mice and rats. Epilepsia 27:483-489
28. Patsalos PN, Alavijeh MS, Brownhill W, Lascelles PT (1988) Effects of denzimol on carbamazepine and carbamazepine-10,11-epoxide concentrations in serum, liver, spleen and different brain regions of the rat: an inhibitory metabolic interaction. Naunyn-Schmiedeberg's Arch Pharmacol 337:111-114
29. Pellegrino LJ, Pellegrino AS, Cushman AJ (1979) A stereotaxic atlas of the rat brain, 2nd edn. Plenum Press, New York
30. Pellock JM (1994) Standard approach to antiepileptic drug treatment in the United States. Epilepsia 35 [Suppl 4]:S11-S18
31. Rambeck B, Schnabel R, May T, Jürgens U, Villagran R (1990) Postmortem serum protein binding and brain Concentrations of antiepileptic drugs in autoptic specimens from 45 epileptic patients. Ther Drug Monit 12:533-540
32. Rea MA, Ferriera S, Randolph W, Glass JD (1993) Daily profile of the extracellular concentration of glutamate in the suprachiasmatic region of the siberian hamster. Pioc Soc Exp Biol Med 204:104-109
33. Renno WM, Mullett MA, Beitz AJ (1992) Systemic morphine reduces GABA release in the lateral but not the medial portion of the midbrain periaqueductal gray of the rat. Brain Res 594:221-232
34. Rogawski ME, Porter RJ (1990) Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol Rev 42:223-286
35. Schmutz M, Brugger F, Gentsch C, McLean MJ, Olpe HR (1994) Preclinical anticonvulsant profile and putative mechanisms of action. Epilepsia 35 [Suppl 5]:S47-S50
36. Schwarz JR, Grigat G (1989) Phenytoin and carbamazepine: potential- and frequency-dependent block of Na currents in mammalian myelinated nerve fibers. Epilepsia 30:286-294
37. Waldmeier PC, Baumann PA, Wicki P, Feldtrauer J-J, Stierlin C, Schmutz M (1995) Similar potency of carbamazepine, oxcarbazepine and lamotrigine in inhibiting the release of glutamate and other neurotransmitters. Neurology 45:1907-1913
38. Wamil AW, Portet Ch, Jensen PK, Schmutz M, McLean MJ (1991) Oxcarbazepine and its monohydroxy metabolite limit action potential firing by mouse central neurons in cell culture. Epilepsia 32 [Suppl 3]:65-66
39. Wamil AW, Schmutz M, Portet C, Feldmann KF, McLean MJ (1994) Oxcarbazepine and its monohydroxy metabolite limit action potential of neurons in vitro and protect rodents against generalized tonic-clonic seizures. Eur J Pharmacol 271:301-308
40. Willow M, Kuenzel EA, Catterall WA (1983) Inhibition of voltage sensitive sodium channels in neuroblastoma cells and synaptosomes by the anticonvulsant drugs diphenylhydantoin and carbamazepine. Mol Pharmacol 25:228-234
41. Young AMJ, Bradford HF (1986) Excitatory amino acid transmitters in the corticostriatal pathway: studies using intracerebral microdialysis in vivo. J Neurochem 47:1399-1404
42. Yuen AWC (1991) Lamotrigine . In: Pisani F, Perucca E, Avanzini G, Richens A (eds) New antiepileptic drugs. Elsevier, Amsterdam, pp 115-123
43. Yuen AWC (1994) Lamotrigine: a review of antiepileptic efficacy. Epilepsia 35 [Suppl 5]:S33-S36